BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nemati M, Bani F, Sepasi T, Zamiri RE, Rasmi Y, Kahroba H, Rahbarghazi R, Sadeghi MR, Wang Y, Zarebkohan A, Gao H. Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles. Mol Pharm 2021;18:4341-53. [PMID: 34779630 DOI: 10.1021/acs.molpharmaceut.1c00525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu Y, Luan Y, Dai W. Time evolution of protein corona formed by polystyrene nanoplastics and urease. Int J Biol Macromol 2022;218:72-81. [PMID: 35870622 DOI: 10.1016/j.ijbiomac.2022.07.104] [Reference Citation Analysis]
2 Xiao Q, Zoulikha M, Qiu M, Teng C, Lin C, Li X, Sallam MA, Xu Q, He W. The effects of protein corona on in vivo fate of nanocarriers. Adv Drug Deliv Rev 2022;186:114356. [PMID: 35595022 DOI: 10.1016/j.addr.2022.114356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Jiang Z, Chu Y, Zhan C. Protein corona: challenges and opportunities for targeted delivery of nanomedicines. Expert Opin Drug Deliv 2022;:1-14. [PMID: 35738018 DOI: 10.1080/17425247.2022.2093854] [Reference Citation Analysis]
4 Ding J, Guo Y. Recent Advances in Chitosan and its Derivatives in Cancer Treatment. Front Pharmacol 2022;13:888740. [DOI: 10.3389/fphar.2022.888740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Farshbaf M, Valizadeh H, Panahi Y, Fatahi Y, Chen M, Zarebkohan A, Gao H. The impact of protein corona on the biological behavior of targeting nanomedicines. Int J Pharm 2022;614:121458. [PMID: 35017025 DOI: 10.1016/j.ijpharm.2022.121458] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]